Cardio-Thoracic-Vascular Department, Cardiovascular Radiology Unit, and Cardiology Institute, University Hospital S. Orsola, Via Massarenti 9, Bologna, Italy.
Circ Cardiovasc Imaging. 2010 Jul;3(4):351-9. doi: 10.1161/CIRCIMAGING.109.880625. Epub 2010 May 11.
Multidetector CT coronary angiography (MDCTCA) is capable of detecting coronary artery disease (CAD) with a high diagnostic accuracy. In particular, this technique is credited with having a negative predictive value close to 100%. However, data about the prognostic value of MDCTCA are currently lacking. We sought to determine the prognostic value of MDCTCA in patients with suspected but undocumented CAD and, in particular, the incremental prognostic value as compared with clinical risk and calcium scoring.
A total of 441 patients (age, 59.7+/-11.6 years) with suspected CAD underwent MDCTCA to evaluate the presence and severity of the disease. Patients were followed up as to the occurrence of hard cardiac events (cardiac death, nonfatal myocardial infarction, and unstable angina requiring hospitalization). Coronary lesions were detected in 297 (67.3%) patients. During a mean follow-up of 31.9+/-14.8 months, 44 hard cardiac events occurred in 40 patients. CT calcium scoring showed a statistically significant incremental prognostic value as compared to a baseline clinical risk model (P=0.018), whereas MDCTCA provided an additional incremental prognostic value as compared with a baseline clinical risk model plus calcium scoring if considering both nonobstructive versus obstructive CAD (P=0.016) or, better, plaque composition (calcified versus noncalcified and/or mixed plaques, P=0.0001). During follow-up, an excellent prognosis was noted in patients with normal coronary arteries, with an annualized incidence rate of 0.88% if compared with those with mild CAD (3.89%) and with patients with significant coronary disease (8.09%). The presence of noncalcified or mixed plaques, regardless of lesion severity, was found to be the strongest predictor of events (P<0.0001) as a potential marker of plaque vulnerability.
MDCTCA provides independent and incremental prognostic information as compared to baseline clinical risk factors and calcium scoring in patients with suspected CAD.
多排螺旋 CT 冠状动脉造影(MDCTCA)能够以较高的诊断准确率检测出冠状动脉疾病(CAD)。特别是,该技术的阴性预测值接近 100%。然而,目前缺乏关于 MDCTCA 预后价值的数据。我们旨在确定 MDCTCA 在疑似但未经记录 CAD 患者中的预后价值,特别是与临床风险和钙评分相比的增量预后价值。
共有 441 例(年龄 59.7+/-11.6 岁)疑似 CAD 的患者接受 MDCTCA 以评估疾病的存在和严重程度。对患者进行硬心脏事件(心脏死亡、非致命性心肌梗死和需要住院治疗的不稳定型心绞痛)的发生情况进行随访。在 297 例(67.3%)患者中检测到冠状动脉病变。在平均 31.9+/-14.8 个月的随访期间,40 例患者中有 44 例发生硬心脏事件。与基线临床风险模型相比,CT 钙评分显示出统计学上显著的增量预后价值(P=0.018),而如果考虑非阻塞性与阻塞性 CAD(P=0.016)或更好的斑块组成(钙化与非钙化和/或混合斑块,P=0.0001),则 MDCTCA 与基线临床风险模型加钙评分相比提供了额外的增量预后价值。在随访期间,与轻度 CAD(3.89%)和严重 CAD 患者(8.09%)相比,正常冠状动脉患者的预后良好,年化发生率为 0.88%。无论病变严重程度如何,非钙化或混合斑块的存在被发现是事件的最强预测因素(P<0.0001),作为斑块易损性的潜在标志物。
与基线临床危险因素和钙评分相比,MDCTCA 为疑似 CAD 患者提供了独立且增量的预后信息。